Baidu
map

NEJM:继发性梅毒-病例报道

2020-10-01 MedSci原创 MedSci原创

荧光性视网膜蛋白抗体吸收测试具有反应性。人类免疫缺陷病毒测试为阴性。诊断为继发性梅毒。原发感染可能无症状;最初的无痛下疳可能不会引起注意。

患者为一名62岁的男子,因全身无力和弥漫性皮疹2周而到急诊就诊。

经检查,他的体温为38.1°C。体格检查发现他的手掌(如图A所示)、脚底(如图B所示)和躯干(如图C所示)出现斑丘疹,色素沉着和鳞屑疹。生殖器上也有色素沉着斑块。他有与多个伴侣无保护性交史,但没有生殖器下疳或溃疡。

该患者进行了快速血浆反应素测试,结果显示滴度为1:128。荧光性视网膜蛋白抗体吸收测试具有反应性。人类免疫缺陷病毒测试为阴性。诊断为继发性梅毒。原发感染可能无症状;最初的无痛下疳可能不会引起注意。

该患者接受了肌内青霉素G苄星胺治疗,随访3个月后皮疹完全消退,血浆快速滴度降低至1:32。

原始出处:

Priyanka Bhugra,et al.Secondary Syphilis.N Engl J Med 2020;https://www.nejm.org/doi/full/10.1056/NEJMicm2001103

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1952696, encodeId=a3611952696b3, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jan 30 23:16:35 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724527, encodeId=72051e2452760, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Fri Dec 25 20:16:35 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035436, encodeId=81fa103543652, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Oct 01 22:16:35 CST 2020, time=2020-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889608, encodeId=7de8889608ae, content=厉害厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpJVcpECMUATt5iaMc09c4WsFcnLwnayPsFkPE92Gibj9T6rMfhSvaZhnjV8SeXr6Bcl4ddfC4m9Cg/132, createdBy=7d5c2384333, createdName=kulou0314, createdTime=Thu Oct 01 20:29:54 CST 2020, time=2020-10-01, status=1, ipAttribution=)]
    2021-01-30 xzw113
  2. [GetPortalCommentsPageByObjectIdResponse(id=1952696, encodeId=a3611952696b3, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jan 30 23:16:35 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724527, encodeId=72051e2452760, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Fri Dec 25 20:16:35 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035436, encodeId=81fa103543652, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Oct 01 22:16:35 CST 2020, time=2020-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889608, encodeId=7de8889608ae, content=厉害厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpJVcpECMUATt5iaMc09c4WsFcnLwnayPsFkPE92Gibj9T6rMfhSvaZhnjV8SeXr6Bcl4ddfC4m9Cg/132, createdBy=7d5c2384333, createdName=kulou0314, createdTime=Thu Oct 01 20:29:54 CST 2020, time=2020-10-01, status=1, ipAttribution=)]
    2020-12-25 feifers
  3. [GetPortalCommentsPageByObjectIdResponse(id=1952696, encodeId=a3611952696b3, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jan 30 23:16:35 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724527, encodeId=72051e2452760, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Fri Dec 25 20:16:35 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035436, encodeId=81fa103543652, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Oct 01 22:16:35 CST 2020, time=2020-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889608, encodeId=7de8889608ae, content=厉害厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpJVcpECMUATt5iaMc09c4WsFcnLwnayPsFkPE92Gibj9T6rMfhSvaZhnjV8SeXr6Bcl4ddfC4m9Cg/132, createdBy=7d5c2384333, createdName=kulou0314, createdTime=Thu Oct 01 20:29:54 CST 2020, time=2020-10-01, status=1, ipAttribution=)]
    2020-10-01 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1952696, encodeId=a3611952696b3, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jan 30 23:16:35 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724527, encodeId=72051e2452760, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Fri Dec 25 20:16:35 CST 2020, time=2020-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035436, encodeId=81fa103543652, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Oct 01 22:16:35 CST 2020, time=2020-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889608, encodeId=7de8889608ae, content=厉害厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpJVcpECMUATt5iaMc09c4WsFcnLwnayPsFkPE92Gibj9T6rMfhSvaZhnjV8SeXr6Bcl4ddfC4m9Cg/132, createdBy=7d5c2384333, createdName=kulou0314, createdTime=Thu Oct 01 20:29:54 CST 2020, time=2020-10-01, status=1, ipAttribution=)]
    2020-10-01 kulou0314

    厉害厉害

    0

相关资讯

NEJM:妊娠性类天疱疮-病例报道

妊娠性类天疱疮是一种罕见的自身免疫性皮肤病,其特征是起疱,通常表现在妊娠中后期。

NEJM:播散性淋球菌感染-病例报道

鉴于高度怀疑播散性淋球菌感染,该患者开始使用头孢曲松和阿奇霉素治疗。血培养生长革兰氏阴性双球菌,其被鉴定为淋病奈瑟氏球菌,证实了诊断。

这样的皮疹不是湿疹,只有补锌才能好

现在大家对湿疹的认识逐渐增多,可以比较容易的分清楚湿疹和痱子、痤疮等的区别的,如果还分不清楚,那看下面的文章

全身多处反复皮疹伴严重瘙痒 此病1987年由我国医生命名

21岁女性,全身多处反复发生皮疹伴有严重瘙痒1年余,皮损增厚、瘙痒进行性加重半年。以“湿疹”抗过敏对症治疗,皮疹用药后减轻,停药后再次复发。后以“痒疹”口服抗过敏药物,外用卤米松软膏、去炎松尿素乳膏等,及口服中草药治疗,疗效不明显。原来是一新型痒疹作怪,由龙振华教授于1987年首先提出并命名。

NEJM:孢子丝菌病-病例报道

孢子丝菌病是由全球发现的二形真菌申克孢子丝菌复合物引起的亚急性至慢性感染。感染通常涉及皮肤和皮下组织,并且通过皮肤从植物和土壤接种真菌而发生。免疫功能低下的人患播散性疾病的风险较高。

NEJM:确诊9个月后死亡!这种皮疹极易误诊

看到皮疹,我们一般首先想的是皮肤科,但是,有时候皮疹的背后可能隐藏着呼吸科的严重问题。究竟什么情况下,皮疹要查肺癌呢?《新英格兰医学杂志》(NEJM)的这个病例会给我们很多启发。

Baidu
map
Baidu
map
Baidu
map